Inhibiting 5-fluorouracil breakdown: a broken down approach to 5-fluorouracil modulation
- PMID: 12453336
- DOI: 10.1016/S1533-0028(11)70502-3
Inhibiting 5-fluorouracil breakdown: a broken down approach to 5-fluorouracil modulation
Comment on
-
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer.Clin Colorectal Cancer. 2002 May;2(1):43-50. doi: 10.3816/CCC.2002.n.010. Clin Colorectal Cancer. 2002. PMID: 12453335 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
